HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
From June 8 to 12, our team had the honor of attending the ISHAS Congress, held this year in Illinois, USA.
This world-renowned event, organized every two years, brings together the global scientific community focused on Hyaluronic Acid. It is recognized for its exceptionally high level of academic and clinical content, with a strong emphasis on research, innovation, and scientific progress.
We were proud to contribute to the program with a speaking engagement, and to share the stage with top international experts in the field. It was a valuable opportunity to present our insights, exchange with peers, and stay at the forefront of scientific advancement.
We’re already looking forward to the next edition of this outstanding congress.
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
HTL Biotechnology is proud to support National Biomedicines manufacturing Day, which will take place on June 5, 2025.
HTL Biotechnology CEO François Fournier spoke to leading Korean media DongA Ilbo, reaffirming Korea’s strategic importance and the strong, long-standing ties with Korean customers.